Table 2. Characteristics of the sample of patients whose medical records were analyzed before and after the intervention.
| Variables | Before intervention (n = 93) | After intervention (n = 97) | p value | |
|---|---|---|---|---|
| Age (years) | 62.8 ± 15.4 | 64.1 ± 13.3 | 0.535 | |
| Sex (n) | 51 (54.8) | 48 (49.5) | 0.460 | |
| Type of DM (n) | 0.083 | |||
| DM1 | 5 (5.4) | 2 (2.1) | ||
| DM2 | 63 (67.7) | 79 (81.4) | ||
| HH | 25 (26.9) | 16 (16.5) | ||
| Duration of diabetes (years) | 10 (2 - 15) | 6 (2 - 10) | 0.660 | |
| HbA1C (%) | 8.7 (6.7 - 12.6) | 7.3 (6.6 – 10.5) | 0.153 | |
| Hospitalized for DM (n) | 9 (9.7) | 3 (3.1) | 0.062 | |
| Main diagnosis at discharge (n) | ||||
| Cancer | 30 (32.3) | 28 (28.9) | 0.612 | |
| Infection | 15 (16.1) | 15 (15.5) | 0.900 | |
| Covid-19 | 1 (1.1) | 23 (23.3) | <0.001 | |
| Presence of comorbidities (n) | 86 (92.5) | 93 (95.9) | 0.315 | |
Data presented as mean ± standard deviation, n (%) and median (interquartile range).
DM: diabetes mellitus; DM1: diabetes mellitus type 1; DM2: diabetes mellitus type 2; HH: hospital hyperglycemia; HbA1C: glycated hemoglobin.